Benzinga | Feb 11, 2021 04:16PM EST

Chemours Q4 EPS $0.61 Beats $0.41 Estimate, Sales $1.30B Beat $1.28B Estimate

Chemours (NYSE:CC) reported quarterly earnings of $0.61 per share which beat the analyst consensus estimate of $0.41 by 48.78 percent. This is a 8.93 percent increase over earnings of $0.56 per share from the same period last year. The company reported quarterly sales of $1.30 billion which beat the analyst consensus estimate of $1.28 billion by 1.56 percent. This is a 3.92 percent decrease over sales of $1.35 billion the same period last year.